Cargando…
Pricing of orphan drugs in oncology and rare diseases
Objective: The objective of this paper is to determine an upper price limit for an orphan drug by taken a broader perspective and, including also other monetary and non-monetary values for the society. Methods: This model is based on the expected free cash flows and the required minimum rate of retu...
Autores principales: | Nuijten, Mark, Capri, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Routledge
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717868/ https://www.ncbi.nlm.nih.gov/pubmed/33312455 http://dx.doi.org/10.1080/20016689.2020.1838191 |
Ejemplares similares
-
The impact of early phase price agreements on prices of orphan drugs
por: Nuijten, Mark, et al.
Publicado: (2021) -
A comparative study of orphan drug prices in Europe
por: Young, Katherine Eve, et al.
Publicado: (2017) -
Establishing a reasonable price for an orphan drug
por: Berdud, Mikel, et al.
Publicado: (2020) -
Pricing Zolgensma – the world’s most expensive drug
por: Nuijten, Mark
Publicado: (2021) -
Variables affecting pricing of orphan drugs: the Italian case
por: Jommi, Claudio, et al.
Publicado: (2021)